Shorter Glucocorticoid Treatment Combined with Rituxan Could Benefit Some AAV Patients, Study Says
A shorter glucocorticoid treatment course, given in combination with Rituxan (rituximab), may be beneficial for some patients with ANCA-associated vasculitis, a study shows. The study, “Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial,” was published in the journal Seminars in Arthritis and Rheumatism. While modern…